Regulus Therapeutics Statistics
Total Valuation
Cameco has a market cap or net worth of $31.75 billion. The enterprise value is $31.96 billion.
| Market Cap | 31.75B |
| Enterprise Value | 31.96B |
Important Dates
The last earnings date was Thursday, July 31, 2025, before market open.
| Earnings Date | Jul 31, 2025 |
| Ex-Dividend Date | Nov 27, 2024 |
Share Statistics
Cameco has 435.39 million shares outstanding. The number of shares has increased by 0.03% in one year.
| Current Share Class | 435.39M |
| Shares Outstanding | 435.39M |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 434.23M |
Valuation Ratios
The trailing PE ratio is 81.16 and the forward PE ratio is 53.81.
| PE Ratio | 81.16 |
| Forward PE | 53.81 |
| PS Ratio | 12.13 |
| Forward PS | n/a |
| PB Ratio | 6.42 |
| P/TBV Ratio | 6.46 |
| P/FCF Ratio | 48.59 |
| P/OCF Ratio | 37.41 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 45.59, with an EV/FCF ratio of 48.91.
| EV / Earnings | 81.70 |
| EV / Sales | 12.21 |
| EV / EBITDA | 45.59 |
| EV / EBIT | 72.80 |
| EV / FCF | 48.91 |
Financial Position
The company has a current ratio of 2.96, with a Debt / Equity ratio of 0.15.
| Current Ratio | 2.96 |
| Quick Ratio | 1.73 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 1.05 |
| Debt / FCF | 1.13 |
| Interest Coverage | 9.16 |
Financial Efficiency
Return on equity (ROE) is 8.25% and return on invested capital (ROIC) is 4.82%.
| Return on Equity (ROE) | 8.25% |
| Return on Assets (ROA) | 3.95% |
| Return on Invested Capital (ROIC) | 4.82% |
| Return on Capital Employed (ROCE) | 6.67% |
| Revenue Per Employee | $1.08M |
| Profits Per Employee | $161,389 |
| Employee Count | 2,424 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 2.69 |
Taxes
In the past 12 months, Cameco has paid $117.59 million in taxes.
| Income Tax | 117.59M |
| Effective Tax Rate | 23.11% |
Stock Price Statistics
The stock price has increased by +60.32% in the last 52 weeks. The beta is 1.22, so Cameco's price volatility has been higher than the market average.
| Beta (5Y) | 1.22 |
| 52-Week Price Change | +60.32% |
| 50-Day Moving Average | 69.65 |
| 200-Day Moving Average | 54.52 |
| Relative Strength Index (RSI) | 45.82 |
| Average Volume (20 Days) | 5,076,300 |
Short Selling Information
The latest short interest is 18.44 million, so 4.24% of the outstanding shares have been sold short.
| Short Interest | 18.44M |
| Short Previous Month | 18.31M |
| Short % of Shares Out | 4.24% |
| Short % of Float | 4.25% |
| Short Ratio (days to cover) | 3.27 |
Income Statement
In the last 12 months, Cameco had revenue of $2.62 billion and earned $391.21 million in profits. Earnings per share was $0.89.
| Revenue | 2.62B |
| Gross Profit | 931.49M |
| Operating Income | 439.02M |
| Pretax Income | n/a |
| Net Income | 391.21M |
| EBITDA | 701.12M |
| EBIT | 439.02M |
| Earnings Per Share (EPS) | $0.89 |
Balance Sheet
The company has $525.19 million in cash and $738.60 million in debt, giving a net cash position of -$213.40 million or -$0.49 per share.
| Cash & Cash Equivalents | 525.19M |
| Total Debt | 738.60M |
| Net Cash | -213.40M |
| Net Cash Per Share | -$0.49 |
| Equity (Book Value) | 4.94B |
| Book Value Per Share | 11.35 |
| Working Capital | 874.77M |
Cash Flow
In the last 12 months, operating cash flow was $848.65 million and capital expenditures -$187.79 million, giving a free cash flow of $653.46 million.
| Operating Cash Flow | 848.65M |
| Capital Expenditures | -187.79M |
| Free Cash Flow | 653.46M |
| FCF Per Share | $1.50 |
Margins
Gross margin is 35.58%, with operating and profit margins of 16.77% and 14.94%.
| Gross Margin | 35.58% |
| Operating Margin | 16.77% |
| Pretax Margin | 19.44% |
| Profit Margin | 14.94% |
| EBITDA Margin | 26.78% |
| EBIT Margin | 16.77% |
| FCF Margin | 24.96% |
Dividends & Yields
This stock pays an annual dividend of $0.08, which amounts to a dividend yield of 0.11%.
| Dividend Per Share | $0.08 |
| Dividend Yield | 0.11% |
| Dividend Growth (YoY) | 28.64% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 9.28% |
| Buyback Yield | -0.03% |
| Shareholder Yield | 0.09% |
| Earnings Yield | 1.23% |
| FCF Yield | 2.06% |
Analyst Forecast
The average price target for Cameco is $85.82, which is 17.67% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $85.82 |
| Price Target Difference | 17.67% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on February 23, 2006. It was a forward split with a ratio of 2:1.
| Last Split Date | Feb 23, 2006 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Cameco has an Altman Z-Score of 7.63 and a Piotroski F-Score of 7.
| Altman Z-Score | 7.63 |
| Piotroski F-Score | 7 |